Governance Genmab A/S

GMAB

DK0010272202

Biotechnology & Medical Research

Market Closed - Nasdaq Copenhagen Other stock markets 09:50:00 11/12/2025 pm IST			5-day change	1st Jan Change
2,046.00 ^DKK	+2.74%		+1.14%	+37.09%

02:50am	Genmab A/S - Special Call
10/12	BillionToOne Q3 Swings to Profit, Revenue Rises; Shares Fall After Hours	MT

Executive Committee: Genmab A/S

Manager

Positions heldSince

Jan van de Winkel

64 year

Chief Executive Officer	01/06/2010
Founder	11/06/1998
President	01/06/2010

Andrew Carlsen

Investor Relations Contact

Rayne Waller

Chief Tech/Sci/R&D Officer

16/08/2024

Christopher Cozic

47 year

Human Resources Officer

01/01/2017

Tahamtan Ahmadi

52 year

Chief Tech/Sci/R&D Officer

01/02/2021

Anthony Pagano

47 year

Director of Finance/CFO

01/03/2020

Gregory David Emil Mueller

54 year

General Counsel

01/07/2025

Composition of the Board of Directors: Genmab A/S

Director

CommitteesSince

Deirdre Connelly

64 year

Compensation Committee	26/03/2020
Governance Committee Chair	26/03/2020
Nominating Committee Chair	26/03/2020
Audit Committee	26/03/2020
Executive Committee
Governance Committee	10/08/2016
Compensation Committee Chair	26/05/2016
Finance Committee	26/03/2020

Anders Gersel Pedersen

74 year

Governance Committee	01/11/2003
Nominating Committee	01/11/2003
Compensation Committee Chair	01/01/2020
Audit Committee	01/01/2020
Finance Committee	01/01/2014
Nominating Committee Chair	01/01/2020

Elizabeth O'Farrell

60 year

Audit Committee	29/03/2022
Compensation Committee Chair	01/01/2020
Audit Committee Chair	01/02/2021
Finance Committee	29/03/2022
Compensation Committee	29/03/2022

Pernille Erenbjerg

58 year

Governance Committee	01/01/2015
Nominating Committee	01/01/2015
Audit Committee Chair	27/04/2022
Finance Committee Chair	01/01/2015

Rolf K. Hoffmann

65 year

Audit Committee	01/01/2017
Finance Committee	01/01/2017
Compensation Committee	15/06/2023
Nominating Committee	15/06/2023

Paolo Augusto Paoletti

74 year

Compensation Committee

Mijke Zachariasse

52 year

Director/Board Member

29/03/2019

Martin Schultz

50 year

Director/Board Member

01/01/2022

Latest Appointments: Genmab A/S

10/12	BillionToOne Q3 Swings to Profit, Revenue Rises; Shares Fall After Hours	MT
29/09	Top Midday Stories: Electronic Arts Going Private in $55 Billion Deal; Genmab to Acquire Merus for $8 Billion	MT
29/09	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Monday Ahead of Trump, Democrats Meeting	MT
01/07	Genmab Announces Changes to Its Executive Committee	CI
01/07	Genmab's Chief Legal Officer Steps Down; Successor Named	MT
20/12	Aadi Bioscience, Inc. Appoints Baiteng Zhao to its Board of Directors	CI
30/24/30	HOOKIPA Pharma Names Julie O'Neill Nonexecutive Chair	MT

More news

Former Officers and Directors: Genmab A/S

Insider

Positions held

SinceUntil

Birgitte Stephensen

General Counsel

01/07/2025

Anthony Mancini

Chief Operating Officer

23/03/2020

16/08/2024

Takahiro Hamatani

Director/Board Member

01/01/2022

Jonathan Peacock

Director/Board Member	26/03/2020	15/11/2021
Independent Dir/Board Member	26/03/2020	15/11/2021

Suba Krishnan

Corporate Officer/Principal

01/09/2019

01/11/2020

Michael K. Bauer

Chief Tech/Sci/R&D Officer	-	01/10/2020
Corporate Officer/Principal	01/08/2012	-

Mats Gunnar Pettersson

Director/Board Member	17/04/2013	-
Chairman	17/04/2013	26/03/2020
Independent Dir/Board Member	17/04/2013	26/03/2020

David Andrew Eatwell

Director of Finance/CFO

02/06/2008

29/02/2020

Richard Gordon Hibbert

Director/Board Member

01/01/2016

29/03/2019

Rachel Curtis Gravesen

Investor Relations Contact	01/05/2011	11/03/2019
Public Communications Contact	01/05/2011	11/03/2019

Rima Bawarsh Nassar

Director/Board Member

01/01/2019

Burt Malkiel

Director/Board Member	01/04/2010	01/06/2018
Independent Dir/Board Member	01/01/2007	01/06/2018

Paul W. H. I. Parren

Chief Tech/Sci/R&D Officer

01/09/2001

01/08/2017

Steen Lisby

Chief Tech/Sci/R&D Officer

01/01/2008

01/01/2017

Peter Storm Kristensen

Director/Board Member

01/01/2016

Hans Henrik Munch-Jensen

Director/Board Member	26/03/2009	01/01/2015
Independent Dir/Board Member	01/01/2007	01/01/2015

Michael Blair Widmer

Director/Board Member	28/03/2012	01/04/2013
Chairman	01/03/2002	27/04/2012
Independent Dir/Board Member	01/03/2002	01/04/2013

Daniel John Bruno

Comptroller/Controller/Auditor	01/01/2008	01/04/2013
Director/Board Member	25/06/2010	01/04/2013
Comptroller/Controller/Auditor	01/01/2016	-
Director/Board Member	01/01/2016	01/08/2020

Karsten Havkrog Pedersen

Director/Board Member	01/03/2002	01/04/2013
Independent Dir/Board Member	01/03/2002	01/04/2013

Antonius Theodorus M Wilderbeek

Director/Board Member	06/04/2011	01/04/2013
Independent Dir/Board Member	06/04/2011	01/04/2013

Patrick van Berkel

Chief Tech/Sci/R&D Officer

01/01/2003

01/01/2012

Helle Husted

Investor Relations Contact	28/04/2011	01/05/2011
Public Communications Contact	-	28/04/2011

Joris Wilms

Corporate Officer/Principal

01/10/2008

01/12/2010

Eva Ehrnrooth

Chief Tech/Sci/R&D Officer

01/06/2008

01/02/2010

Lisa N. Drakeman

Founder	01/01/1999	01/01/2010
President	01/01/1999	01/01/2010

Ernst H. Schweizer

Director/Board Member

26/03/2009

15/04/2009

Barry Littlejohns

Chief Operating Officer

28/05/2010

Bo Kruse

Comptroller/Controller/Auditor	01/01/2000	01/01/2005
Director of Finance/CFO	01/01/2005	02/06/2008

Claus Juan Møller-San Pedro

Chief Operating Officer

01/01/1999

01/01/2008

Irwin Lerner

Director/Board Member

31/01/2007

Hanne Jensen

Corporate Officer/Principal

01/01/1999

Christina Hahner

Chief Administrative Officer	01/01/2005	-
Public Communications Contact	01/01/2005	-

Annarie Lyles

Corporate Officer/Principal

28/05/2010

Joseph Fred Yospe

Comptroller/Controller/Auditor

01/09/2002

01/09/2004

Nedjad Losic

Director/Board Member	25/06/2010	-
Corporate Officer/Principal	01/01/2004	-

Michael Wolff Jensen

Director of Finance/CFO

01/01/2000

01/01/2003

Jorgen Petersen

Chief Tech/Sci/R&D Officer

01/01/2002

Tom Vink

Director/Board Member	25/06/2010	-
Corporate Officer/Principal	01/01/2002	-

Rikke Glahn Ren

Corporate Officer/Principal

01/01/2001

Ole Baadsgaard

Chief Tech/Sci/R&D Officer	28/05/2010	-
Corporate Officer/Principal	28/05/2010	28/05/2010

Donald Lee Drakeman

Founder

11/06/1998

Florian Schönharting

Founder

11/06/1998

Jesper Zeuthen

Chairman

Francesco de Rubertis

Director/Board Member

Linda Basse

Chief Tech/Sci/R&D Officer

Flemming Heise Pedersen

Director/Board Member

Eva Steiness

Chairman

Dorrit T. Andersen

General Counsel

Torben Lund-Hansen

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	15
Female	4

Of which Executive Committee

Male	7
Female	0

Of which Directors

Male	5
Female	3

Revisions

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Genmab A/S specializes in the research and development of human and therapeutic antibodies intended for treating cancers, infectious diseases, rheumatoid arthritis, etc. Net sales break down by type of income as follows: - royalties (80.6%); - income from research and development (9.3%); - other (10.1%): primarily income from partnership agreement. At the end of 2024, the group had a portfolio of more than 20 products in clinical development phase and 20 in preclinical development phase. Net sales are distributed geographically as follows: Denmark (91.9%), the United States (4.2%) and Japan (3.9%).

Employees

2,681

Sector

Biotechnology & Medical Research

Calendar

09:30pm - R&D Day

More about the company